Deutsche Bank AG bought a new position in Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 372,077 shares of the construction company’s stock, valued at approximately $2,359,000.
A number of other hedge funds also recently added to or reduced their stakes in ASPN. Rice Hall James & Associates LLC acquired a new stake in shares of Aspen Aerogels in the 2nd quarter worth about $10,368,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Aspen Aerogels in the 2nd quarter valued at about $682,000. Bank of New York Mellon Corp acquired a new position in Aspen Aerogels during the 2nd quarter valued at about $1,239,000. State of Wyoming acquired a new position in Aspen Aerogels during the 2nd quarter valued at about $241,000. Finally, Royal Bank of Canada grew its position in Aspen Aerogels by 95.8% in the 1st quarter. Royal Bank of Canada now owns 8,523 shares of the construction company’s stock worth $29,000 after purchasing an additional 4,169 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.
Aspen Aerogels Price Performance
Shares of NYSE:ASPN opened at $5.22 on Friday. Aspen Aerogels, Inc. has a 12 month low of $2.30 and a 12 month high of $9.35. The stock has a market cap of $433.54 million, a price-to-earnings ratio of -3.41 and a beta of 2.99. The stock’s 50 day moving average price is $5.42 and its 200 day moving average price is $4.64. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the stock. Wall Street Zen lowered shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Barclays boosted their price objective on Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 11th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Roth Capital reaffirmed a “buy” rating and set a $7.75 target price on shares of Aspen Aerogels in a research note on Friday, August 7th. Finally, B. Riley Financial reiterated a “buy” rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Aspen Aerogels currently has an average rating of “Hold” and a consensus price target of $5.94.
Get Our Latest Stock Analysis on ASPN
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Featured Articles
- Five stocks we like better than Aspen Aerogels
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN – Free Report).
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
